TABLE 3.
Most Common Antibiotics Received on Day 0, 1, or 2 of Hospitalization Among All Patients With Severe and Nonsevere Pneumonia
| Factor | Total (n = 154,799) | Nonsevere (n = 132,994) | Severe (n = 21,805) |
|---|---|---|---|
| Count (column %) | |||
| Vancomycin | 59,152 (38.2) | 44,668 (33.6) | 14,484 (66.4) |
| Piperacillin/tazobactam | 40,903 (26.4) | 31,413 (23.6) | 9,490 (43.5) |
| Levofloxacin | 57,619 (37.2) | 48,896 (36.8) | 8,723 (40.0) |
| Ceftriaxone | 75,190 (48.6) | 67,372 (50.7) | 7,818 (35.9) |
| Azithromycin | 69,073 (44.6) | 62,126 (46.7) | 6,947 (31.9) |
| Cefepime | 15,720 (10.2) | 12,740 (9.6) | 2,980 (13.7) |
| Any antipseudomonal excluding quinolones | 63,751 (41.2) | 49,579 (37.3) | 14,172 (65.0) |
| Any antipseudomonal including quinolones | 97,565 (63.0) | 80,160 (60.3) | 17,405 (79.8) |
| Any antiviral | 3,112 (2.0) | 2,335 (1.8) | 777 (3.6) |
Comparisons between severe and not severe pneumonia are statistically significant (p < 0.001) by Pearson χ2 test for each antibiotic class.